Turner Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-44,430
| Closed | -$2.25M | – | 283 |
|
|
2016
Q3 | $2.25M | Buy |
+44,430
| New | +$2.25M | 0.74% | 49 |
|
|
2016
Q1 | – | Sell |
-18,000
| Closed | -$1.02M | – | 238 |
|
|
2015
Q4 | $1.02M | Sell |
18,000
-20,000
| -53% | -$1.13M | 0.21% | 136 |
|
|
2015
Q3 | $1.51M | Buy |
38,000
+16,710
| +78% | +$665K | 0.31% | 102 |
|
|
2015
Q2 | $1.02M | Buy |
+21,290
| New | +$1.02M | 0.19% | 168 |
|
|
2014
Q3 | – | Sell |
-303,950
| Closed | -$4.51M | – | 555 |
|
|
2014
Q2 | $4.51M | Sell |
303,950
-240,820
| -44% | -$3.57M | 0.2% | 150 |
|
|
2014
Q1 | $8.77M | Sell |
544,770
-187,802
| -26% | -$3.02M | 0.23% | 158 |
|
|
2013
Q4 | $6.84M | Sell |
732,572
-538,742
| -42% | -$5.03M | 0.12% | 222 |
|
|
2013
Q3 | $14.4M | Sell |
1,271,314
-285,372
| -18% | -$3.23M | 0.24% | 144 |
|
|
2013
Q2 | $20.8M | Buy |
+1,556,686
| New | +$20.8M | 0.28% | 138 |
|